12,819 Shares in Afya Limited (NASDAQ:AFYA) Bought by Wealthedge Investment Advisors LLC

Wealthedge Investment Advisors LLC acquired a new stake in Afya Limited (NASDAQ:AFYA) in the 1st quarter, Holdings Channel reports. The fund acquired 12,819 shares of the company’s stock, valued at approximately $230,000.

Other large investors also recently bought and sold shares of the company. Wellington Management Group LLP acquired a new stake in shares of Afya during the fourth quarter worth about $829,000. BNP Paribas Financial Markets purchased a new position in Afya during the 4th quarter worth approximately $228,000. Cerity Partners LLC acquired a new position in Afya during the first quarter worth approximately $476,000. Yorktown Management & Research Co Inc purchased a new stake in Afya in the first quarter valued at approximately $321,000. Finally, Two Sigma Advisers LP lifted its stake in Afya by 27.2% in the fourth quarter. Two Sigma Advisers LP now owns 78,600 shares of the company’s stock valued at $1,248,000 after buying an additional 16,800 shares during the last quarter. Institutional investors and hedge funds own 88.02% of the company’s stock.

Afya Stock Down 2.3%

AFYA stock opened at $15.06 on Friday. The stock has a market capitalization of $1.41 billion, a PE ratio of 11.41, a price-to-earnings-growth ratio of 0.54 and a beta of 0.53. The company has a fifty day moving average of $16.11 and a 200-day moving average of $17.22. The company has a debt-to-equity ratio of 0.22, a quick ratio of 1.42 and a current ratio of 0.94. Afya Limited has a one year low of $13.47 and a one year high of $19.90.

Wall Street Analyst Weigh In

A number of equities analysts have recently issued reports on AFYA shares. Citigroup upgraded shares of Afya from a “sell” rating to a “neutral” rating and lowered their target price for the stock from $16.00 to $14.00 in a research report on Tuesday, July 29th. UBS Group reissued a “neutral” rating and set a $19.50 price objective (up from $17.50) on shares of Afya in a research report on Thursday, June 12th. Morgan Stanley set a $17.50 price objective on shares of Afya and gave the company an “overweight” rating in a research note on Wednesday, August 6th. Zacks Research upgraded shares of Afya to a “hold” rating in a research note on Friday, August 8th. Finally, Wall Street Zen cut Afya from a “buy” rating to a “hold” rating in a research report on Saturday, July 26th. One equities research analyst has rated the stock with a sell rating, five have assigned a hold rating and one has assigned a buy rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of “Hold” and a consensus price target of $17.50.

Afya Profile

Afya Limited, through its subsidiaries, operates as a medical education group in Brazil. The company operates through three segments: Undergrad, Continuing Education, and Digital Services. It offers educational products and services, including medical schools, medical residency preparatory courses, graduate courses, and other programs to lifelong medical learners enrolled across its distribution network, as well as to third-party medical schools.